Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00203918 · ClinicalTrials.gov registry record

Prostate Cancer Utilities and Cost-Effectiveness Analysis

A clinical trial, sponsored by University of Chicago.

Completed
Registry status
481
Enrollment target

NCT00203918: Completed study, sponsored by University of Chicago.

NCT00203918 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 481 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00203918 has completed, sponsored by University of Chicago.

COMPLETED
Registry status
481 participants
Enrollment target

Study Summary

The purpose of this study is to help doctors and patients make better decisions about prostate cancer treatment. This research is being done because we do not know how patient preferences for health states related to prostate cancer affect the final treatment decision.

Primary Outcome

Patient utility scores (i.e. patient preference weights) are calculated using survery data will determine which prostate cancer treatment would be most cost-effective for each subject. Patients will be contacted by phone and patient records will be reviewed 90 days after the survey has been completed to determine whether this data reflects actual treatment decisions.

Interventions

  • BEHAVIORAL Survey, interview
  • BEHAVIORAL patient utility scores (i.e. patient preference weights)

Trial Details

FieldValue
Enrollment Target 481 participants
Start Date 2004-01
Est. Completion 2013-02
University of Chicago

796 total trials

What the finished NCT00203918 record still lists

NCT00203918 is an observational study that tracks outcomes without assigning an intervention. The registered 481 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which Survey, interview is the first listed.

NCT00203918 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00203918 about?

NCT00203918 is a clinical study titled "Prostate Cancer Utilities and Cost-Effectiveness Analysis". The purpose of this study is to help doctors and patients make better decisions about prostate cancer treatment. This research is being done because we do not know how patient preferences for health states related to prostate cancer affect the final treatment decision.

What is the current status of trial NCT00203918?

This trial is currently completed. The enrollment target is 481 participants. The study started on 2004-01. Estimated completion is 2013-02.

What interventions are being tested in trial NCT00203918?

The interventions under investigation include: Survey, interview (BEHAVIORAL), patient utility scores (i.e. patient preference weights) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00203918?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04449458 · 482 participants · NA

    The Positively Quit Trial for Smoking Cessation

  • NCT07079631 · 482 participants · Phase 1

    A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

  • NCT01954992 · 480 participants · Phase 3

    Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

  • NCT03023696 · 480 participants · NA

    Can Prophylactic Foraminotomy Prevent C5 Palsy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00203918, the US trial registry maintained by the National Library of Medicine. NCT00203918 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.